valacyclovir
Generic: valacyclovir
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
valacyclovir
Generic Name
valacyclovir
Labeler
preferred pharmaceuticals inc.
Dosage Form
TABLET
Routes
Active Ingredients
valacyclovir hydrochloride 1000 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8705
Product ID
68788-8705_b4046250-4f62-4395-8cd0-cdd31edca208
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209553
Listing Expiration
2026-12-31
Marketing Start
2024-07-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888705
Hyphenated Format
68788-8705
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
valacyclovir (source: ndc)
Generic Name
valacyclovir (source: ndc)
Application Number
ANDA209553 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1000 mg/1
Packaging
- 6 TABLET in 1 BOTTLE (68788-8705-0)
- 10 TABLET in 1 BOTTLE (68788-8705-1)
- 20 TABLET in 1 BOTTLE (68788-8705-2)
- 30 TABLET in 1 BOTTLE (68788-8705-3)
- 4 TABLET in 1 BOTTLE (68788-8705-4)
- 15 TABLET in 1 BOTTLE (68788-8705-5)
- 21 TABLET in 1 BOTTLE (68788-8705-7)
Packages (7)
68788-8705-0
6 TABLET in 1 BOTTLE (68788-8705-0)
68788-8705-1
10 TABLET in 1 BOTTLE (68788-8705-1)
68788-8705-2
20 TABLET in 1 BOTTLE (68788-8705-2)
68788-8705-3
30 TABLET in 1 BOTTLE (68788-8705-3)
68788-8705-4
4 TABLET in 1 BOTTLE (68788-8705-4)
68788-8705-5
15 TABLET in 1 BOTTLE (68788-8705-5)
68788-8705-7
21 TABLET in 1 BOTTLE (68788-8705-7)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b4046250-4f62-4395-8cd0-cdd31edca208", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["3146e367-8438-4141-9368-95ce6f59c724"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "6 TABLET in 1 BOTTLE (68788-8705-0)", "package_ndc": "68788-8705-0", "marketing_start_date": "20240701"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (68788-8705-1)", "package_ndc": "68788-8705-1", "marketing_start_date": "20240701"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-8705-2)", "package_ndc": "68788-8705-2", "marketing_start_date": "20240701"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8705-3)", "package_ndc": "68788-8705-3", "marketing_start_date": "20240701"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE (68788-8705-4)", "package_ndc": "68788-8705-4", "marketing_start_date": "20240701"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (68788-8705-5)", "package_ndc": "68788-8705-5", "marketing_start_date": "20240701"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (68788-8705-7)", "package_ndc": "68788-8705-7", "marketing_start_date": "20240701"}], "brand_name": "Valacyclovir", "product_id": "68788-8705_b4046250-4f62-4395-8cd0-cdd31edca208", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68788-8705", "generic_name": "Valacyclovir", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20240701", "listing_expiration_date": "20261231"}